Back to results
US 9,518,027 B2Granted
Deuterated momelotinib
AssigneeConcert Pharmaceuticals, Inc.
InventorRobert Silverman
Life of this patent
Estimating the term…
Abstract
The present invention in one embodiment provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
Claims23
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- Y1, Y2, Y3, Y4, Z1, Z2, Z3, Z4, W1 and W2 are each independently selected from hydrogen and deuterium;
- provided that if Y1, Y2, Y3, Y4, Z1, Z2, Z3, Z4, and W1 are each hydrogen, then W2 is deuterium.
Dependencies are inferred from the claim text.